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Abstract:  
Background: Mental health difficulties are highly prevalent, yet access to support is limited 
by barriers of stigma, cost, and availability. These issues are even more prevalent in low- and 
middle-income countries, and digital technology is one potential way to overcome these 
barriers. Digital mental health interventions are effective but often struggle with low 
engagement rates, particularly in the absence of human support. Chatbots could offer a 
scalable solution, simulating human support at a lower cost. Objective: To complete a 
preliminary evaluation of engagement and effectiveness of Vitalk, a mental health chatbot, at 
reducing anxiety, depression and stress. Methods: Real world data was analysed from 3629 
Vitalk users who had completed the first phase of a Vitalk program (‘less anxiety,’ ‘less 
stress’ or ‘better mood’). Programs were delivered through written conversation with a 
chatbot. Engagement was calculated from the number of responses sent to the chatbot divided 
by days in the program. Results:  Users sent an average of 8.17 responses per day. For all 
three programs, target outcome scores reduced between baseline and follow up with large 
effect sizes for anxiety (Cohen's d = -0.85), depression (Cohen's d = -0.91) and stress 
(Cohen's d =-0.81).  Increased engagement resulted in improved post-intervention values for 
anxiety and depression.  Conclusion: This study highlights a chatbot’s potential to reduce 
mental health symptoms in the general population within Brazil. While findings show 
promise, further research is required. 
2 
Introduction 
Mental health disorders are highly prevalent, yet numbers accessing treatment are low (1,2). 
Reasons cited for this discrepancy include structural barriers such as a lack of availability, high 
cost and attitudinal barriers such as perceived stigma (3,4). Advances in digital technology 
along with increases in internet access and smartphone ownership could offer an opportunity 
to overcome some of these barriers, bringing relative anonymity and scalability at a lower cost 
(5,6).  
There is growing empirical support for use of digital technology in mental health, where web 
platforms or smartphone applications are used to deliver evidence-based interventions. These 
digital interventions are effective, feasible and acceptable to users (7–9), although are 
associated with low engagement and poor adherence (10,11). Adherence rates and outcomes 
appear more favourable when active human support or guidance is integrated into the digital 
tool (12,13), but this limits scalability. The development of conversational agents, or chatbots 
could offer an interesting solution (14,15). Chatbots take a conversational approach, simulating 
human interaction through written text. This ability to mimic human support could potentially 
improve engagement while enabling scalability through automation. This could be particularly 
interesting in low- and middle- income settings where there are large mental health treatment 
gaps and scarce resources available (6).  
Within mental health, chatbots have been used to deliver psychoeducation, self care strategies 
and skills training and show high satisfaction rates (14,15). The use of chatbots appears feasible 
and acceptable to users (15,16), but there is less certainty on effectiveness. The knowledge base 
is however growing rapidly, with recent studies finding that engaging with a conversational 
agent over relatively short periods can reduce perceived stress (11) and improve symptoms of 
depression (5) and anxiety (5,17). These studies are all RCTs or pilot RCT’s and challenges 
surrounding user engagement means that real world uptake may differ (10). Additionally, the 
studies were all completed in high income countries, with small sample sizes (n<75) and 
recruited from student populations. 
To our knowledge there have been no studies to evaluate the use of mental health chatbots 
within Latin America. This study seeks to explore if a mental health chatbot has the potential 
to be effective within Brazil.  
Aim  
To evaluate real world engagement and effectiveness of Vitalk, a newly developed mental 
health chatbot. The hypothesis is that use of the chatbot will lead to a reduction in symptoms 
of stress, anxiety and depression over a one month period.  
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Methods 
Participants 
Vitalk was installed voluntarily by members of the general population who had found it on the 
hosting platform, through marketing campaigns, word of mouth, or a personal search. Vitalk 
sought to offer conversations about mental health and self help strategies to improve wellbeing. 
Users had installed Vitalk between June and November 2019 and completed one month of a 
Vitalk program (N=3629). All users were Portuguese speakers located in Brazil and over 18 
years of age, with internet access. 
Description of chatbot 
Vitalk is an automated chatbot delivering mental health content in an innovative conversational 
format. It is a free-to-use service, hosted within an instant messenger platform, accessible from 
any internet-enabled device. The chatbot is built on ruby and JavaScript and was created by the 
IT, product development and UX team at TNH Health.  
 
The overall aim of Vitalk is to improve wellbeing by reducing stress, anxiety and depression 
using a preventative approach to mental health. It consists of three core programs, addressing 
themes of anxiety, low mood, and stress. Programs are 90 days in duration, divided into three 
30-day phases. During each phase, the user is engaged in four to five conversations per week, 
each lasting approximately five minutes. Outcome measurement and feedback on scores is built 
into the program, with users completing symptom questionnaires at baseline and the end of 
each phase.  
 
The conversations are based on insights and strategies taken from Cognitive Behavioural 
Therapy (CBT) and Positive Psychology (18,19), which include (but are not limited to) 
psychoeducation, cognitive restructuring, behavioural activation, gratitude, and practical 
exercises such as breathing, relaxation and meditation. The goal of the conversations is to help 
the user reflect on experiences and learn techniques which can help them manage stress, mood 
and anxiety. A mood tracking tool helps to aid reflection, ‘emojis’ and GIFs to mimic a natural 
human interaction and gamification to increase engagement. The chatbot avatar is named Viki 
and was developed through focus groups and piloting with users. The conversations used by 
Viki are written by a team of Clinical Psychologists and healthcare professionals and shaped 
by a user experience (UX) team who work on the style and design of the chatbot. This involves 
adapting including the words language used to make the language more accessible to the user. 
 
Figure 1 - screenshot of Vitalk check-up 
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The chatbot initiates conversations, and the user can reply by picking a predefined answer 
option (Figure 1). The predefined options customize the conversation to suit user needs and 
preferences. In some cases, the user can also enter free text, for example between conversations 
or if they want to interrupt the flow. Natural language understanding (NLU) triggers 
conversational modules based on keywords identified from the text entered by the user, which 
then loops back to the pre-programmed conversations. As an example of free text, if the user 
types ‘good morning’ the greetings module is triggered and the chatbot will respond to the 
greeting, ask how the user is feeling and offer a suitable activity. In a situation where the user 
types words directly or indirectly linked to suicidality such as “life isn’t worth living”, the risk 
module is triggered and the chatbot delivers crisis information. This is continuously refined 
and adapted to ensure the language and emotional expression matches that of the user.  
 
Vitalk does not aim to replace a healthcare professional or to offer treatment. Users are made 
aware of this in the terms and conditions they consent to, and they are advised to seek additional 
support if they show a high risk of depression or anxiety during the assessment. Where the 
system identifies a risk issue, the user is sent details of support services, including the national 
suicide line, and where appropriate, a follow up conversation with a healthcare professional 
from Vitalk is initiated.  
Measures 
Generalized Anxiety Disorder (GAD-7)  
The GAD-7 is a 7-item self-report scale used to assess anxiety symptoms over the past two 
weeks (e.g., how often have you been bothered by feeling afraid something awful might 
happen). Scores range from 0 (not at all) to 3 (nearly every day) with a total of 21. The total 
scores are divided into four categories: none (0-4), mild (5-9), moderate (10-14) and severe 
(15+) symptoms  (20,21) 
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The Patient Health Questionnaire (PHQ-9) 
The PHQ-9 is a 9 item self-report scale that evaluates symptoms of depression over the past 
two weeks (e.g., how often have you been bothered by feeling down, depressed, or hopeless). 
Item response options use a Likert scale ranging from 0 (not at all) to 3 (nearly every day). 
Total scores are divided into five categories: none (0-4), mild (5-9), moderate (10-14), 
moderately severe (15-19) and severe (20+) symptoms  (22,23). 
Depression, Anxiety and Stress Scale (DASS-21) - Stress Subscale  
The DASS-21 is a 21 item self-report questionnaire consisting of three scales to measure 
depression, anxiety, and stress. Only the stress subscale was used, this consists of 7 items, and 
the user is asked how much each statement applies to them in the past week (e.g., I found it 
difficult to relax). Scores range from 0 (did not apply) to 3 (applied very much or most of the 
time). Total scores are doubled and divided into five categories: normal (0-14), mild (15-18), 
moderate (19-25), severe (26-33) and extremely severe (34+) levels of stress (24,25).  
 
All scales have been translated into Brazilian Portuguese and are validated for use within this 
population.  
Procedures 
After installing Vitalk, users complete a sign-up process that includes consenting to their 
anonymized data being used for research purposes. The user is then engaged in a conversation 
with the chatbot, who welcomes them to Vitalk and together they complete the baseline 
outcome measures. User responses are recorded and scored by the chatbot, and the user receives 
customized feedback based on their scores. The user then chooses which of the three programs 
to complete, or they can ask the chatbot to recommend one based on their scores.  
 
After a program has been selected, the core content is scheduled for delivery to the user over 
the course of 30 days. When new content is delivered, the user is alerted to a new message, and 
they choose whether to engage in the conversation. The responses of the user shape the 
conversation. Original content is delivered on the next scheduled day, regardless of previous 
engagement. The user can discontinue the program or close their account at any time.  
 
At the end of phase one (day 30), the outcome measure corresponding to the active program is 
repeated (GAD-7 for the anxiety program, PHQ-9 for low mood, DASS-21 for stress). At this 
point, the user can continue with the program they are in or swap to another program if their 
goal has shifted. A full check-up consisting of all three measures is repeated at the end of the 
program (day 90).  
 
For this study, we explored results from the first phase of each program to ascertain early 
engagement and explore initial effects.  
Data collection and privacy 
The study involved real-world data obtained from an anonymous, non-clinical population. 
The users agreed to the terms of service and privacy policy when they signed up, which 
includes giving consent for their anonymized data to be used for research purposes. Access to 
the chatbot requires a login and is password protected, and data gathered by Vitalk is stored 
on a secure server. Data were extracted from the server, anonymized and provided to the 
authors for data analysis. Demographic data was collected by the hosting platform who 
provided this to TNH Health in an aggregated format.  
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Statistical analysis 
Three sets of univariate analyses were conducted with data collected from the GAD-7, PHQ-
9 and DASS-21 stress scales. Engagement with Vitalk was quantified as a rate measure by 
dividing the number of messages sent by the number of days in the program. Descriptive 
statistics were used to describe centrality and distribution of pre-post scale values, severity of 
symptoms and engagement. To describe the magnitude of change across the intervention, 
average based change was quantified with Cohen’s d and standard reference values (0.2: 
“small”, 0.5: “medium”, and ≥0.8: “large” used to qualitatively describe the effect) (26). 
 
d = (Mpost - Mpre ) / Sdiff 
 
Where M is the mean and Sdiff is the standard deviation of the change in scale values across the 
intervention. For the PHQ-9 and GAD-7 scales, reliable change and clinical caseness was 
assessed. For each scale, the Reliable Change Index was calculated by multiplying the standard 
error of the difference by 1.96 (27).  
𝑆𝑆𝐸𝐸𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 = 𝑆𝑆𝑝𝑝𝑝𝑝𝑝𝑝√2√1− 𝑟𝑟 
𝑆𝑆𝑝𝑝𝑝𝑝𝑝𝑝 is the standard deviation of pre-intervention values and 𝑟𝑟 is the reliability obtained in 
validation studies of each scale (28). To be considered reliable, change in scale values across 
the intervention had to exceed 5.9 for the PHQ-9 and 3.7 for the GAD-7. 
 
Clinical caseness was examined by calculating the number of people who were above the 
clinical cut off at baseline and moved below this cut off at follow-up. The number of these 
people that experienced a reliable change was also quantified. A cut-off score of ≥10 was used 
for the PHQ-9, and ≥8 for the GAD-7.  
 
Modelling of post scale values were completed with pre scale values and engagement included 
as predictor variables. Because the scales used can exhibit floor and ceiling effects with many 
observations at the upper value, tobit regression models were used to deal with the truncated 
nature of the data and limit biased estimates that can be obtained with Ordinary Least Squares 
Regression (29). All statistical analyses were conducted in R version 3.5.3 (30). 
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Results 
In total, 3629 users were included in this study. They were located across Brazil; the majority 
were female (76%) and aged 18-24 years (52%). (536/1648, 32.5%).  
Symptom change 
Less anxiety program 
 
In total, 1,648 (45.4%) users completed the first phase of the anxiety program.  
 
Table 1: Classification of anxiety symptoms pre- and post-intervention (% of participants in 
each classification using GAD-7) 
 None Mild Moderate Severe 
Pre 58 (3.5%) 484 (29.4%) 570 (34.6%) 536 (32.5%) 
Post 382 (23.2%) 764 (46.4%) 311 (18.9%) 191 (11.6%) 
 
The average anxiety score (GAD-7) reduced from moderate anxiety (mean 12.2, SD = 4.7) to 
mild anxiety (mean 8.1, SD = 4.7). This reduction was -4.1± 4.8 (t(1647)=-34.3, p<0.001) with 
Cohen’s d = -0.85 indicating a large effect. The percentage of reliable improvement and reliable 
decline was equal to 52.2% and 4.7%, respectively. In terms of clinical caseness, 655 (49.0%) 
users who were above the clinical cut-off at baseline moved to below clinical cut-off at follow 
up (GAD-7 ≥8), 557 (41.6%) of whom also showed reliable improvement).  
Better mood program 
In total 1243 users (34.3%) completed the first phase of the depression program. 
 
Table 2: Classification of depression symptoms pre- and post-intervention (% of participants 
in each classification using PHQ-9) 
 None Mild Moderate Moderately 
Severe 
Severe 
Pre 43 (3.5%) 230 (18.5%) 249 (20.0%) 297 (23.9%) 424 (34.1%) 
Post 210 (16.9%) 480 (38.6%) 250 (20.1%) 156 (12.6%) 147 (11.8%) 
 
The average depression score (PHQ-9) reduced from a moderately severe level (mean 15.9, SD 
= 6.5) to a moderate level (mean 10.4, SD = 6.5). This reduction was -5.5± 6.0 (t(1242)=-31.9, 
p<0.001) with Cohen’s d = -0.91 indicating a large effect. The percentage of reliable 
improvement and reliable decline was equal to 45.1% and 2.3%, respectively. In terms of 
clinical caseness 449 (46.3%) of users who were above the clinical cut-off at baseline moved 
to below clinical cut-off at follow up (PHQ-9 total score ≥10), of whom 370 (38.1%) also 
showed reliable improvement. 
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Less stress program 
In total, 738 users (20.34%) completed the first phase of the stress program. 
 
Table 3: Classification of stress symptoms pre- and post-intervention (% of participants in each 
classification using DASS-21 stress scale) 
 Normal Mild Moderate Severe Extremely 
Severe 
Pre 113 (15.3%) 72 (9.8%) 138 (18.7%) 242 (32.8%) 173 (23.4%) 
Post 349 (47.3%) 101 (13.7%) 122 (16.5%) 112 (15.2%) 54 (7.3%) 
 
Within this period, the average stress score (DASS-21 stress scale) was reduced from severe 
levels (mean 25.8, SD 9.1) to mild levels (mean 17.5, SD = 9.3). This reduction was -8.3± 10.3 
(t(737)=-21.9, p<0.001) with Cohen’s d = -0.81 indicating a large effect. The percentage of 
reliable improvement and reliable decline was equal to 60.3% and 9.2%, respectively.  
Engagement 
In terms of engagement, the average number of responses sent by users to Vitalk per day (total 
responses divided by days in program) within the first phase of the program was 8.17 (SD, 
3.67), with a range of between 0.29 to 40.25 responses.  
 
Tobit regression models were used to assess the effects of engagement on intervention 
effectiveness after controlling for pre-intervention values (Table 4, supplementary material). 
Increased engagement resulted in improved post-intervention values for anxiety and depression 
(p<0.01) but not stress (p= 0.716). No interaction effect was identified between engagement 
and pre-intervention values for any of the outcomes measured (p≥0.08). 
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Discussion 
Initial results indicate that the use of a mental health chatbot within this population can engage 
users and significantly reduce symptoms of anxiety, depression and levels of stress. Higher 
engagement with the chatbot, as measured by the number of responses sent by the user was 
also found to predict lower anxiety and depressive symptoms at follow up. To our knowledge 
this is the first study to examine the use of a mental health chatbot in Latin America, and results 
appear promising.   
 
The majority of the sample were adult females under 24 years of age (52% 18-24 years, 76% 
female). This differed somewhat to the typical demographic profile of the host platform (29% 
25-34 years, 54% female) (31) but it is not clear if this reflects the chatbot appealing more to 
this demographic, differing mental health prevalence rates (32), levels of help seeking 
behaviour (33) or marketing bias.  
 
Baseline levels of anxiety and depression were significantly higher than would be expected in 
the general population in Brazil based on previous research using the same measures (34,35). 
This was not unexpected given users had actively sought out a mental health tool but does 
indicate that Vitalk is able to successfully reach its target audience and could be a useful way 
to engage individuals experiencing elevated stress and mental health symptoms. This finding 
fits with the idea that people recruited through methods that imply more active treatment-
seeking such as a Google or Facebook search, present with high levels of anxiety and 
depression than through more passive methods (36). Interestingly, those recruited by online 
advertisements have been found to have similar levels of depression and anxiety as those 
recruited from clinical settings, suggesting the chatbot could be an helpful way to widen access 
and identify those most at risk, facilitating access to appropriate professional support (36). 
 
Reliable improvements were found in all three programs with symptoms of anxiety, depression 
and stress reducing between baseline and follow up with large effect sizes. These findings are 
in line with other chatbot studies (5,17,37) but with a much larger sample size and suggests 
applicability within Brazil. Interestingly, large numbers of users showed clinically significant, 
reliable change, moving from a clinical to non-clinical range for anxiety and depression as 
measured by the PHQ-9 and GAD-7. Whilst this requires follow-up and further investigation, 
these initial results are extremely promising. It is unclear why there is such a magnitude of 
change, but one hypothesis is that participants had independently sought out a mental health 
tool and so were likely to have high motivation and a readiness to change.  
Limitations 
This study presents preliminary data obtained over a brief engagement period without a control 
group. While an early response is found to be a strong predictor of the treatment outcome (38), 
there is a need to complete a more rigorous study with a control group and longer follow up 
before drawing any firm conclusions. It is hoped that the evidence presented in this paper will 
direct further clinical research and help in the planning of new technological interventions 
within this population.  
 
Within this study, we had limited information on the users of Vitalk due to the method of data 
collection within the host platform. The lack of individual-level demographics limited the 
analysis. In future work it would be important to obtain more detailed information and a deeper 
understanding of users, for example, individual-level demographics and data on education 
levels and socio-economic status which may impact outcomes. It would also be interesting to 
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explore if the users have had any psychological intervention in the past and if they are doing 
so currently. This would offer insight into who Vitalk is reaching, and if for example it is being 
used as an adjunct or follow on from therapy or as the only intervention being accessed. This 
would offer interesting learning for the wider health system.  
 
Due to the study being retrospective, we defined engagement level as the average daily number 
of responses sent by the user, as this was the best measure based on the type of data available. 
However, this did not consider that some conversations are longer than others and the user may 
not be active every day. Exploring alternative engagement metrics would be useful to enrich 
our understanding of how the chatbot is used and would enable more comparison within the 
literature. Analyzing engagement for each conversation would also allow a more granular 
understanding of the impact of specific intervention techniques on symptom change. This 
would allow us to explore which are the most impactful components, whether this be the 
chatbot, mood tracking, specific cognitive behavioral techniques or a combination of all three.  
Conclusion 
As there is currently very little research on the use of chatbots in mental healthcare, particularly 
within low- and middle-income countries, these early findings are promising. The study 
highlights the potential of using such an innovative tool to engage users and offer an effective 
intervention to improve mental health in Brazil’s general population. While findings show 
promise, more rigorous research is required before any firm conclusions can be drawn. 
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Table 4: Tobit regression models quantifying the effect of pre-intervention values and 
engagement with Vitalk as predictors of post-intervention anxiety, depression and stress values  
 Anxiety (0 to 21) 
GAD-7 
Depression (0 to 27) 
PHQ-9 
Stress (0 to 42) 
DASS-21 
Base Model: No 
interaction 
Standardized 
coefficients (β) 
Standardized 
coefficients (β) 
Standardized 
coefficients (β) 
Intercept 8.1 *** 10.4 *** 17.2  *** 
Pre 2.2 *** 3.8 *** 3.4 *** 
Engagement -0.33 ** -0.46 ** 0.11 
    
Full Model: With 
interaction 
   
Intercept 8.1 *** 10.4 *** 17.2 *** 
Pre 2.2 *** 3.7 *** 3.4 *** 
Engagement -0.33 ** -0.45 ** 0.13 
Interaction 
(Pre:Engagement) 
-0.07 -0.26 -0.19 
Pre and engagement variables were standardized by subtracting mean and dividing by the 
standard deviation.  *** p<0.001, ** p<0.01 
 
 
 
